Progyny (NASDAQ:PGNY) Issues Q3 2022 Earnings Guidance
Progyny (NASDAQ:PGNY) Issues Q3 2022 Earnings Guidance
Progyny (NASDAQ:PGNY – Get Rating) issued an update on its third quarter 2022 earnings guidance on Thursday morning. The company provided EPS guidance of $0.02-$0.03 for the period, compared to the consensus EPS estimate of $0.06. The company issued revenue guidance of $190.00 million-$197.00 million, compared to the consensus revenue estimate of $192.00 million. Progyny also updated its FY 2022 guidance to $0.14-$0.19 EPS.
週四上午,普羅吉尼(納斯達克代碼:PGNY-GET Rating)發佈了2022年第三季度收益指引的最新數據。該公司為該季度提供的每股收益指引為0.02至0.03美元,而市場普遍預期的每股收益為0.06美元。該公司發佈的營收指引為1.9億至1.97億美元,而市場普遍預期的營收為1.92億美元。Progyny還將其2022財年每股收益指引更新為0.14-0.19美元。
Progyny Stock Performance
Progyny股票表現
NASDAQ PGNY traded up $11.38 on Friday, hitting $41.15. 3,469,925 shares of the stock were exchanged, compared to its average volume of 684,594. The firm has a market capitalization of $3.78 billion, a P/E ratio of 89.46, a P/E/G ratio of 21.71 and a beta of 1.85. The stock has a fifty day moving average price of $30.23 and a two-hundred day moving average price of $37.32. Progyny has a 52-week low of $25.67 and a 52-week high of $68.32.
上週五,納斯達克PGNY股價上漲11.38美元,至41.15美元。該股成交3469,925股,而平均成交量為684,594股。該公司的市值為37.8億美元,市盈率為89.46,市盈率為21.71,貝塔係數為1.85。該股的50日移動均線價格為30.23美元,200日移動均線價格為37.32美元。Progyny的52周低點為25.67美元,52周高點為68.32美元。
Progyny (NASDAQ:PGNY – Get Rating) last released its quarterly earnings data on Thursday, August 4th. The company reported $0.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.04. Progyny had a net margin of 7.39% and a return on equity of 18.11%. The business had revenue of $195.00 million during the quarter, compared to analyst estimates of $190.51 million. During the same period last year, the business earned $0.19 EPS. Progyny's revenue was up 51.5% compared to the same quarter last year. Sell-side analysts expect that Progyny will post 0.17 earnings per share for the current fiscal year.
納斯達克(納斯達克代碼:PGNY-GET Rating)上一次發佈季度收益數據是在8月4日星期四。該公司公佈本季度每股收益為0.09美元,比分析師普遍預期的0.05美元高出0.04美元。Progyny的淨利潤率為7.39%,股本回報率為18.11%。該業務本季度營收為1.95億美元,而分析師預期為1.9051億美元。去年同期,該業務每股收益為0.19美元。與去年同期相比,Progyny的收入增長了51.5%。賣方分析師預計,Progyny本財年每股收益將為0.17美元。
Insider Buying and Selling
內幕買賣
Institutional Inflows and Outflows
機構資金流入和流出
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Yousif Capital Management LLC boosted its stake in Progyny by 1.1% during the first quarter. Yousif Capital Management LLC now owns 37,264 shares of the company's stock valued at $1,915,000 after buying an additional 392 shares during the last quarter. Captrust Financial Advisors boosted its position in shares of Progyny by 25.0% during the first quarter. Captrust Financial Advisors now owns 2,091 shares of the company's stock valued at $107,000 after purchasing an additional 418 shares in the last quarter. Prudential Financial Inc. boosted its position in shares of Progyny by 6.4% in the 1st quarter. Prudential Financial Inc. now owns 10,603 shares of the company's stock worth $545,000 after purchasing an additional 637 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Progyny during the first quarter worth about $62,000. Finally, Parkside Financial Bank & Trust acquired a new stake in Progyny during the first quarter valued at approximately $70,000. 82.51% of the stock is owned by hedge funds and other institutional investors.
對衝基金和其他機構投資者最近買賣了該股的股票。Yousif Capital Management LLC在第一季度將其在Progyny的持股增加了1.1%。Yousif Capital Management LLC現在擁有37,264股該公司股票,價值1,915,000美元,上個季度又購買了392股。CapTrust Financial Advisors在第一季度將其在Progyny股票的頭寸增加了25.0%。CapTrust Financial Advisors在上個季度額外購買了418股後,現在擁有2,091股該公司股票,價值10.7萬美元。保誠金融第一季度將其在Progyny股票的持倉增加了6.4%。保誠金融現在持有10,603股該公司股票,價值545,000美元,該公司在上個季度又購買了637股。Lazard Asset Management LLC在第一季度收購了Progyny價值約62,000美元的新股。最後,Parkside Financial Bank&Trust在第一季度收購了Progyny的新股份,價值約為7萬美元。82.51%的股票由對衝基金和其他機構投資者持有。
About Progyny
關於Progyny
(Get Rating)
(獲取評級)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny,Inc.是一家福利管理公司,專門為美國僱主提供生育和家庭建設福利解決方案。其生育福利解決方案包括差異化福利計劃設計、個性化禮賓式會員支持服務和有選擇的生育專家網絡。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- Why Apple Could Be At All-Time Highs By Year End
- 免費獲取StockNews.com關於Progyny的研究報告(PGNY)
- MarketBeat:回顧中的一週8/1-8/5
- 如何利用高貝塔係數股票最大化你的投資利潤
- 克羅諾斯集團(Cronos Group Inc.)營收上升,是時候收購了嗎?
- Beyond Meat不是沒有希望,而且它很便宜
- 蘋果為何可能在年底創下歷史新高
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Progyny和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。